Compare Stocks: DH, AMWL, HCAT, and OPRX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMWL American Well	$10.44 -3.0%	$9.69	$3.71 ▼ $13.45	$178.10M	1.68	151,913 shs	144,647 shs
DH Definitive Healthcare	$0.70	$0.79	$0.62 ▼ $4.70	$73.87M	1.35	210,396 shs	273,000 shs
HCAT Health Catalyst	$2.28 +3.2%	$1.93	$0.96 ▼ $3.88	$163.31M	1.55	639,739 shs	471,649 shs
OPRX OptimizeRx	$6.85 +4.6%	$5.75	$4.54 ▼ $22.25	$122.91M	1.08	243,358 shs	176,890 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMWL American Well	-0.48%	-3.08%	+15.65%	+68.47%	+55.29%
DH Definitive Healthcare	+2.59%	+3.92%	-10.22%	-27.26%	-81.28%
HCAT Health Catalyst	+5.74%	+2.79%	+6.25%	+38.13%	-37.22%
OPRX OptimizeRx	+8.26%	+2.66%	+5.82%	-1.21%	-47.60%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMWL American Well	$10.44 -3.0%	$9.69	$3.71 ▼ $13.45	$178.10M	1.68	151,913 shs	144,647 shs
DH Definitive Healthcare	$0.70	$0.79	$0.62 ▼ $4.70	$73.87M	1.35	210,396 shs	273,000 shs
HCAT Health Catalyst	$2.28 +3.2%	$1.93	$0.96 ▼ $3.88	$163.31M	1.55	639,739 shs	471,649 shs
OPRX OptimizeRx	$6.85 +4.6%	$5.75	$4.54 ▼ $22.25	$122.91M	1.08	243,358 shs	176,890 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMWL American Well	-0.48%	-3.08%	+15.65%	+68.47%	+55.29%
DH Definitive Healthcare	+2.59%	+3.92%	-10.22%	-27.26%	-81.28%
HCAT Health Catalyst	+5.74%	+2.79%	+6.25%	+38.13%	-37.22%
OPRX OptimizeRx	+8.26%	+2.66%	+5.82%	-1.21%	-47.60%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMWL American Well	2.00	Hold	$8.60	-17.62% Downside
DH Definitive Healthcare	1.89	Reduce	$2.47	253.06% Upside
HCAT Health Catalyst	2.23	Hold	$2.93	28.59% Upside
OPRX OptimizeRx	2.56	Moderate Buy	$13.43	96.04% Upside

Current Analyst Ratings Breakdown

Latest DH, AMWL, HCAT, and OPRX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/28/2026	HCAT Health Catalyst	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/23/2026	HCAT Health Catalyst	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
7/21/2026	HCAT Health Catalyst	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$2.00 ➝ $3.00
7/17/2026	AMWL American Well	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/17/2026	AMWL American Well	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$9.00 ➝ $16.00
6/29/2026	DH Definitive Healthcare	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy ➝ Underperform	$0.70
6/26/2026	HCAT Health Catalyst	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$1.00 ➝ $1.75
6/24/2026	HCAT Health Catalyst	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/8/2026	AMWL American Well	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$7.50
6/3/2026	DH Definitive Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
5/14/2026	OPRX OptimizeRx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)

(Data available from 8/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMWL American Well	$249.32M	0.69	N/A	N/A	$14.97 per share	0.70
DH Definitive Healthcare	$241.52M	0.31	$1.94 per share	0.36	$2.66 per share	0.26
HCAT Health Catalyst	$311.14M	0.54	$2.19 per share	1.04	$3.47 per share	0.66
OPRX OptimizeRx	$109.43M	1.17	$1.03 per share	6.66	$6.88 per share	1.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMWL American Well	-$95.70M	-$5.42	N/A	N/A	N/A	-37.02%	-32.11%	-24.12%	8/4/2026 (Estimated)
DH Definitive Healthcare	-$138.93M	-$1.62	N/A	23.33	11.30	-76.04%	4.04%	1.99%	8/10/2026 (Estimated)
HCAT Health Catalyst	-$177.97M	-$3.72	N/A	N/A	N/A	-87.69%	-3.52%	-1.77%	8/6/2026 (Estimated)
OPRX OptimizeRx	$5.13M	$0.35	19.57	11.42	N/A	6.37%	10.86%	7.93%	8/12/2026 (Estimated)

Latest DH, AMWL, HCAT, and OPRX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	OPRX OptimizeRx	$0.11	N/A	N/A	N/A	$20.20 million	N/A
8/10/2026	Q2 2026	DH Definitive Healthcare	$0.04	N/A	N/A	N/A	$55.48 million	N/A
8/6/2026	Q2 2026	HCAT Health Catalyst	$0.02	N/A	N/A	N/A	$69.00 million	N/A
8/4/2026	Q2 2026	AMWL American Well	-$0.86	-$0.59	+$0.27	-$0.59	$49.87 million	$52.05 million
5/12/2026	Q1 2026	OPRX OptimizeRx	$0.01	$0.14	+$0.13	-$0.03	$18.74 million	$19.84 million
5/11/2026	Q1 2026	HCAT Health Catalyst	$0.01	$0.02	+$0.01	-$1.53	$69.24 million	$70.76 million
5/7/2026	Q1 2026	DH Definitive Healthcare	$0.03	$0.06	+$0.03	-$1.32	$55.02 million	$55.93 million
5/5/2026	Q1 2026	AMWL American Well	-$0.77	-$0.66	+$0.11	-$0.66	$51.54 million	$54.88 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMWL American Well	N/A	N/A	N/A	N/A	N/A
DH Definitive Healthcare	N/A	N/A	N/A	N/A	N/A
HCAT Health Catalyst	N/A	N/A	N/A	N/A	N/A
OPRX OptimizeRx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMWL American Well	N/A	3.09	3.08
DH Definitive Healthcare	0.81	1.75	1.75
HCAT Health Catalyst	1.10	1.69	1.69
OPRX OptimizeRx	0.16	5.37	5.37

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMWL American Well	56.05%
DH Definitive Healthcare	98.67%
HCAT Health Catalyst	85.00%
OPRX OptimizeRx	76.47%

Insider Ownership

Company	Insider Ownership
AMWL American Well	12.84%
DH Definitive Healthcare	17.09%
HCAT Health Catalyst	19.40%
OPRX OptimizeRx	7.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMWL American Well	1,040	16.55 million	14.43 million	Optionable
DH Definitive Healthcare	970	105.52 million	87.49 million	Not Optionable
HCAT Health Catalyst	1,200	73.89 million	59.56 million	Optionable
OPRX OptimizeRx	100	18.76 million	17.36 million	Optionable

DH, AMWL, HCAT, and OPRX Headlines

Recent News About These Companies

OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

August 1 at 4:43 AM | marketbeat.com

OptimizeRx (OPRX) Projected to Announce Quarterly Earnings on Thursday

July 30, 2026 | marketbeat.com

OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET

July 29, 2026 | globenewswire.com

OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer

July 23, 2026 | globenewswire.com

OptimizeRx (NASDAQ:OPRX) Cut to "Buy" at Wall Street Zen

July 20, 2026 | marketbeat.com

OptimizeRx Corp. (NASDAQ:OPRX) Sees Significant Decline in Short Interest

July 16, 2026 | marketbeat.com

OptimizeRx (NASDAQ:OPRX) Upgraded at Wall Street Zen

July 12, 2026 | marketbeat.com

OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent

June 30, 2026 | globenewswire.com

OptimizeRx Launches AI-Powered Natural Language Audience Builder for DSP and Media Planning Platforms

June 25, 2026 | quiverquant.comQ

OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms

June 25, 2026 | globenewswire.com

OptimizeRx (OPRX) Stock Sees Fair Value Cut As Analysts Reset Growth Expectations

June 18, 2026 | finance.yahoo.com

OptimizeRx: A Good Business That Has Not Yet Earned Back Investor Trust

June 9, 2026 | finance.yahoo.com

OptimizeRx to Participate in Upcoming Investor Conferences

June 1, 2026 | globenewswire.com

OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?

May 28, 2026 | zacks.com

DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network

May 22, 2026 | markets.businessinsider.com

OptimizeRx Corp. and DeepIntent Announce First Integration of EHR Network into Healthcare Advertising Platform

May 21, 2026 | quiverquant.comQ

DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx's Authenticated EHR Network

May 21, 2026 | globenewswire.com

OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?

May 20, 2026 | zacks.com

OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds

May 20, 2026 | zacks.com

B. Riley Securities Remains a Buy on OptimizeRx (OPRX)

May 15, 2026 | theglobeandmail.com

OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?

May 15, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

DH, AMWL, HCAT, and OPRX Company Descriptions

American Well NYSE:AMWL

$10.44 -0.32 (-2.97%)

Closing price 04:00 PM Eastern

Extended Trading

$11.15 +0.71 (+6.80%)

As of 07:38 PM Eastern

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Definitive Healthcare NASDAQ:DH

$0.70 0.00 (0.00%)

Closing price 04:00 PM Eastern

Extended Trading

$0.70 0.00 (-0.29%)

As of 07:34 PM Eastern

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Health Catalyst NASDAQ:HCAT

$2.28 +0.07 (+3.17%)

Closing price 04:00 PM Eastern

Extended Trading

$2.28 0.00 (-0.22%)

As of 07:34 PM Eastern

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

OptimizeRx NASDAQ:OPRX

$6.85 +0.30 (+4.58%)

Closing price 04:00 PM Eastern

Extended Trading

$6.85 0.00 (0.00%)

As of 07:34 PM Eastern

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DH, AMWL, HCAT, and OPRX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DH, AMWL, HCAT, and OPRX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DH, AMWL, HCAT, and OPRX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

DH, AMWL, HCAT, and OPRX Company Descriptions

American Well NYSE:AMWL

Definitive Healthcare NASDAQ:DH

Health Catalyst NASDAQ:HCAT

OptimizeRx NASDAQ:OPRX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DH, AMWL, HCAT, and OPRX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DH, AMWL, HCAT, and OPRX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DH, AMWL, HCAT, and OPRX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

DH, AMWL, HCAT, and OPRX Company Descriptions

American Well NYSE:AMWL

Definitive Healthcare NASDAQ:DH

Health Catalyst NASDAQ:HCAT

OptimizeRx NASDAQ:OPRX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools